RBP2 and chronic myelogenous leukemia, BCR-ABL1 positive: miR-21 expression was significantly reduced with upregulated RBP2 in K562 and HL60 cells (Figures 3B, C) and in primary cells from the bone marrow of CML-CP and CML-BP patients (Figures 3B, C).